Here are the key changes to know about in the New Zealand equity market; F&P Healthcare, Tourism Holdings, Chorus and Gentrack lead today’s NZX50 gains, while Channel Infrastructure, Mainfreight, Kathmandu and Summerset weigh on the index

Here are the key things you need to know about in the NZX markets over the past 24 hours. Changes are as at 3:00 pm and may change when the market closes at 4:45 pm.

WHAT THE NZX 50 INDEX IS DOING
The NZX50 is up +0.5% today, down -0.6% month-on-month. Year-on-year it has gained +6.7%.

THE MAIN GAINERS
There were 43 gainers on the market today, led by Fisher & Paykel Healthcare (FPH, #1), which rose +6% and is up +7% over the past five days and +15% year‑on‑year. Tourism Holdings (THL, #44) gained +4%, up +6% over five days and +37% annually. Chorus (CNU, #12) added +3%, up +7% over five days and +15% year‑on‑year, while Gentrack (GTK, #36) rose +2%, up +8% over five days but remains down -37% year‑on‑year.

THE MAIN DECLINERS
There were 35 decliners, with Channel Infrastructure (CHI, #30) and Mainfreight (MFT, #8) both falling -3%. CHI is down -8% over the month but up +35% year‑on‑year, while Mainfreight is down -7% month‑on‑month and -7% year‑on‑year. Kathmandu Brands (KMD, #50) slipped -2%, extending its -14% monthly decline and sitting -40% below last year’s level. Summerset (SUM, #19) also eased -2%, down -3% over five days and -14% year‑on‑year.

SMARTSHARES EFTs

KEY ANNOUNCEMENTS
Chorus (CNU, #12) delivered a solid HY26 result, with operating revenue rising to $506mln and EBITDA up +3% to $357mln, supported by continued fibre uptake and efficiency gains as the company transitions to an all‑fibre network. Fibre connections increased by 31,000 to 1.13m, now representing 95% of fixed lines, while copper connections fell to around 3,000 ahead of full withdrawal by mid‑2026. Net profit came in at $15mln, compared with a $5mln loss a year earlier, and the interim dividend was lifted +4% to 24c per share. Operating expenses and capital expenditure both declined, reflecting lower maintenance needs and strong capital discipline. Chorus reaffirmed FY26 EBITDA guidance of $710mln–$730mln and expects to pay a 60c full‑year dividend, citing strong demand for high‑quality connectivity and the long‑term value of its fibre network.

Genesis Energy (GNE, #5) posted a record first‑half normalised EBITDAF of $307mln, driven by strong hydro conditions, portfolio flexibility and continued execution of its Gen35 strategy, noting that “this result demonstrates the strength and resilience of Genesis’ diversified portfolio” . The company also announced a $400mln equity raise via a $100mln placement and a $300mln rights offer to accelerate its renewable and firming‑capacity development pipeline, with CEO Malcolm Johns saying the raise will “enable the acceleration of circa NZ$2 bln pipeline of growth opportunities to FY32” . Genesis reaffirmed FY26 EBITDAF guidance of $490mln–$520mln and lifted its FY28 target to the upper $500mln range, while declaring an interim dividend of 7.3c per share.

Fisher & Paykel Healthcare (FPH, #1) has upgraded its FY26 guidance, now expecting full‑year revenue of around $2.30bln and NPAT of $450mln–$470mln, reflecting stronger‑than‑expected second‑half Hospital product growth. The company said efficiency gains are supporting margin improvement, though Northern Hemisphere respiratory seasonality may still influence the result. F&P Healthcare also noted the US Supreme Court’s decision to invalidate IEEPA‑based tariffs, with potential refunds still uncertain as it works through the implications; an update will be provided with full‑year results in May.

Click on the chart title to find more about this sector, including its components.